Comparative study of the pharmacokinetic profiles of two LMWHs—bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)—administered subcutaneously to healthy male volunteers (Q73298374)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 25, 2003

Language	Label	Description	Also known as
English	Comparative study of the pharmacokinetic profiles of two LMWHs—bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)—administered subcutaneously to healthy male volunteers	scientific article published on January 25, 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12706639%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Comparative study of the pharmacokinetic profiles of two LMWHs--bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)--administered subcutaneously to healthy male volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12706639%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Comparative study of the pharmacokinetic profiles of two LMWHs—bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)—administered subcutaneously to healthy male volunteers (English)

1 reference

10.1016/S0049-3848(03)00141-5

https://api.crossref.org/works/10.1016/S0049-3848(03)00141-5

26 December 2023

direct Xa inhibitor

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706639

26 December 2023

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

F. Depasse

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706639

26 December 2023

M. J. González de Suso

2

0000-0001-9448-8593

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706639

26 December 2023

I. Lagoutte

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706639

26 December 2023

J. Fontcuberta

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706639

26 December 2023

M. Borrell

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706639

26 December 2023

M. M. Samama

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706639

26 December 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12706639

26 December 2023

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12706639%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

25 January 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12706639

26 December 2023

full work available at URL

https://api.elsevier.com/content/article/PII:S0049384803001415?httpAccept=text/xml

1 reference

10.1016/S0049-3848(03)00141-5

https://api.crossref.org/works/10.1016/S0049-3848(03)00141-5

26 December 2023

https://api.elsevier.com/content/article/PII:S0049384803001415?httpAccept=text/plain

1 reference

10.1016/S0049-3848(03)00141-5

https://api.crossref.org/works/10.1016/S0049-3848(03)00141-5

26 December 2023

Thrombosis Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12706639%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

109

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12706639%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

2-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12706639%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

109-117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12706639%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900141-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900141-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238)

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900141-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Bioavailability and pharmacokinetics of a new low molecular weight heparin (RO-11)--a three way cross-over study in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900141-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparins: pharmacologic profile and product differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900141-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900141-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue factor pathway inhibitor and anti-FXa kinetic profiles of a new low-molecular-mass heparin, Bemiparin, at therapeutic subcutaneous doses.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900141-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-dependent release of endogenous tissue factor pathway inhibitor by different low molecular weight heparins

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900141-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma TFPI activity after intravenous injection of pentasaccharide (PS) and unfractionated heparin in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900141-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The low molecular weight heparin, tinzaparin, in thrombosis and beyond.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900141-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900141-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue factor pathway inhibitor in complex with low density lipoprotein isolated from human plasma does not possess anticoagulant function in tissue factor-induced coagulation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900141-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900141-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humans

4

1 reference

10.1016/S0049-3848(03)00141-5

https://api.crossref.org/works/10.1016/S0049-3848(03)00141-5

26 December 2023

Low molecular weight heparins: are they different?

11

1 reference

10.1016/S0049-3848(03)00141-5

https://api.crossref.org/works/10.1016/S0049-3848(03)00141-5

26 December 2023

Identifiers

10.1016/S0049-3848(03)00141-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12706639%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12706639%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73298374&oldid=2143666641"